XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 9,491 $ 4,082
Restricted cash 14,292 13,668
Accounts receivable, net 9,145 8,017
Prepaid expenses and other assets 5,231 4,475
Derivative assets 2,071 2,103
Total current assets 40,230 32,345
Property and equipment, net 587,516 588,179
Investment in unconsolidated entity 22,307 0
Other assets, net 2,194 936
Total assets 652,247 621,460
Current liabilities:    
Accounts payable 8,951 11,375
Accrued expenses 37,324 42,388
Current portion of notes payable, net of deferred loan costs 2,235 42,323
Deferred income 4,356 4,041
Federal and state income taxes payable 93 215
Other current liabilities 599 519
Total current liabilities 53,558 100,861
Notes payable, net of deferred loan costs and current portion 581,520 587,099
Other long-term liabilities 31 49
Total liabilities 635,109 688,009
Commitments and contingencies (Note 11)
Redeemable preferred stock:    
Series A convertible preferred stock, $0.01 par value; 41 shares authorized, 41 shares issued and outstanding as of June 30, 2024 and December 31, 2023 51,248 48,542
Shareholders’ deficit:    
Preferred stock 0 0
Common stock 142 82
Additional paid-in capital 366,710 302,992
Retained deficit (400,962) (418,165)
Total shareholders’ deficit (34,110) (115,091)
Total liabilities, redeemable preferred stock and shareholders’ deficit $ 652,247 $ 621,460